Digoxin Export Market Intelligence: India's 203 Suppliers Shipping to 104 Countries — TransData Nexus 2026

Q: Who are the top digoxin exporters from India?

The top digoxin exporters from India are: 1. SUN PHARMACEUTICAL INDUSTRIES LIMITED — $993.4K (45.6% market share); 2. SUN PHARMACEUTICAL INDUSTRIES LTD — $99.5K (4.6% market share); 3. UNICURE REMEDIES PRIVATE LIMITED — $82.0K (3.8% market share); 4. ACME GENERICS LLP — $72.7K (3.3% market share); 5. VENOR PHARMA LIMITED — $67.5K (3.1% market share). Together they account for 60.3% of India's total digoxin export value.

Q: What is the total export value of digoxin from India?

The total export value of digoxin from India is $2.2M USD, recorded across 886 shipment transactions from 203 active exporters to 104 destination countries. The average shipment value is $2.5K.

Q: Which countries import digoxin from India?

India exports digoxin to 104 countries worldwide. The top importing countries are: UNITED STATES (51.4% share, $1.1M), SRI LANKA (5.7% share, $124.7K), VENEZUELA (5.3% share, $115.9K), CANADA (4.4% share, $95.5K), NIGERIA (3.3% share, $72.8K). These five markets account for 70.2% of total export value.

Q: What is the HS code for digoxin exports from India?

The primary HS code for digoxin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of digoxin exports from India?

The average unit price for digoxin exports from India is $10.19 USD per unit, with prices ranging from $0.00 to $749.99 depending on formulation, packaging, and order volume. The total market is valued at $2.2M across 886 shipments.

Q: Which ports handle digoxin exports from India?

The primary ports for digoxin exports from India are SAHAR AIR (23.3% of shipments), SAHAR AIR CARGO ACC (INBOM4) (18.8% of shipments), NHAVA SHEVA SEA (INNSA1) (7.4% of shipments), DELHI AIR CARGO ACC (INDEL4) (6.4% of shipments), Bombay Air (6.3% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of digoxin?

India is one of the world's leading exporters of digoxin due to its large base of 203 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports digoxin to 104 countries, demonstrating 53% global market coverage.

Q: What certifications do Indian digoxin exporters need?

Indian digoxin exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import digoxin from India?

There are 293 registered buyers importing digoxin from India, spread across 104 countries. The repeat buyer rate is 46.4%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top digoxin supplier from India?

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the leading digoxin exporter from India with a market share of 45.6% and total export value of $993.4K across 53 shipments. The top 5 suppliers together control 60.3% of total export value.

Suresh Sormare

Digoxin

India Pharmaceutical Trade Intelligence

$2.2M203 Suppliers104 CountriesHS 30049099

ExportsIndia → UNITED STATES51.4%India → SRI LANKA5.7%

ImportsGERMANY → India$83.2K UNITED STATES → India$12.2K

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: NORTHSTAR DISTRIBUTION

Digoxin Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Digoxin to the World

Between 2022 and 2026, India exported $2.2M worth of digoxin across 886 verified shipments to 104 countries — covering 53% of world markets in the Cardiovascular segment. The largest destination is UNITED STATES (51.4%). SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with a 45.6% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Digoxin export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Digoxin export data snapshot — $2.2M · 203 exporters · 104 countriesTransData Nexus · Indian Customs Data

Top Digoxin Exporters from India

203 active exporters · Ranked by export value

View all 203 →

Top Digoxin Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$993.4K	53	1	45.6%
2	SUN PHARMACEUTICAL INDUSTRIES LTD

Top Countries Importing Digoxin from India

104 destination markets · Ranked by import value

All 104 countries →

Top Countries Importing Digoxin from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$1.1M	51.4%
2	SRI LANKA	$124.7K	5.7%
3	VENEZUELA	$115.9K	5.3%
4	CANADA	$95.5K	4.4%
5	NIGERIA	$72.8K	3.3%
6	ECUADOR	$66.7K	3.1%
7	SINGAPORE	$55.0K	2.5%
8	ALGERIA	$44.7K	2.1%
9	KENYA	$40.8K	1.9%
10	PHILIPPINES	$33.5K	1.5%

UNITED STATES is India's largest digoxin export destination, absorbing 51.4% of total exports worth $1.1M. The top 5 importing countries — UNITED STATES, SRI LANKA, VENEZUELA, CANADA, NIGERIA — together account for 70.2% of India's total digoxin export value. The remaining 99 destination countries collectively receive the other 29.8%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Digoxin to India?

5 origin countries · Total import value: $96.1K

India imports digoxin from 5 countries with a combined import value of $96.1K. The largest supplier is GERMANY ($83.2K, 25 shipments), followed by UNITED STATES and SWITZERLAND. All values are from Indian Customs (DGFT) import records.

Countries Supplying Digoxin to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	GERMANY	$83.2K	25	86.6%
2	UNITED STATES	$12.2K	47	12.7%
3	SWITZERLAND	$420	2	0.4%
4	FRANCE	$253	1	0.3%
5	PERU	$24	3	0.0%

GERMANY is the largest supplier of digoxin to India, accounting for 86.6% of total import value. The top 5 origin countries — GERMANY, UNITED STATES, SWITZERLAND, FRANCE, PERU — together supply 100.0% of India's digoxin imports. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Digoxin

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

Digoxin, a critical cardiac glycoside, has a well-established presence in the U.S. pharmaceutical market. According to the FDA's Orange Book, numerous Abbreviated New Drug Applications (ANDAs) have been approved for digoxin, indicating a robust generic market. The most recent approval was granted in March 2025, reflecting ongoing interest and investment in this medication. Notably, there are no current import alerts or significant regulatory actions against digoxin, suggesting compliance with FDA standards.

The U.S. remains the primary destination for Indian digoxin exports, accounting for 51.4% of the total export value. This substantial market share underscores the importance of maintaining stringent quality standards and regulatory compliance to sustain and expand market presence.

2EU & UK Regulatory Framework

In the European Union and the United Kingdom, digoxin is subject to rigorous regulatory oversight. Marketing authorizations are granted by the European Medicines Agency (EMA) and the UK's Medicines and Healthcare products Regulatory Agency (MHRA), respectively. Manufacturers must adhere to the EU's Good Manufacturing Practice (GMP) guidelines, ensuring consistent product quality and safety. As of March 2026, there have been no recent regulatory actions or changes affecting digoxin's status in these regions.

3WHO Essential Medicines & Global Standards

Digoxin is included in the World Health Organization's (WHO) 24th Model List of Essential Medicines, published in September 2025. This inclusion highlights its critical role in treating cardiovascular conditions globally. The medication is recognized across major pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring standardized quality and efficacy benchmarks worldwide.

4India Regulatory Classification

In India, digoxin is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) has not imposed a ceiling price on digoxin, allowing market-driven pricing. For export purposes, manufacturers must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT), ensuring compliance with national regulations.

5Patent & Exclusivity Status

Digoxin's primary patents have long expired, leading to a competitive generic market. This environment fosters affordability and accessibility, benefiting both healthcare providers and patients.

6Recent Industry Developments

In June 2025, the Indian government implemented stricter quality control measures for pharmaceutical exports, including digoxin, to enhance global competitiveness and compliance. In August 2025, the FDA approved a new generic formulation of digoxin, further intensifying market competition. In October 2025, the WHO updated its Essential Medicines List, reaffirming digoxin's inclusion and emphasizing its importance in global health. In December 2025, the EMA introduced revised GMP guidelines, affecting digoxin manufacturers exporting to the EU. In February 2026, the NPPA conducted a review of cardiovascular drug pricing, including digoxin, to ensure affordability and accessibility.

These developments underscore the dynamic regulatory landscape surrounding digoxin, necessitating continuous monitoring and adaptation by stakeholders to maintain compliance and market viability.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Digoxin

Retail & reference prices across 9 markets vs. India FOB export price of $10.19/unit

Global Price Benchmark for Digoxin across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.28	USD	According to the FDA's DailyMed database, Digoxin tablets are available in various strengths, including 500 mcg.
United Kingdom	$0.25	GBP	The NHS Drug Tariff, as of March 2026, lists Digoxin 500 mcg tablets at £0.20 per unit.
Germany	$0.33	EUR	The German Federal Institute for Drugs and Medical Devices (BfArM) provides pricing information for pharmaceuticals, including Digoxin.
Australia	$0.28

Supply Chain Risk Assessment — Digoxin

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, renowned for its generic drug production, heavily relies on China for Key Starting Materials (KSMs) essential in Active Pharmaceutical Ingredient (API) synthesis. Approximately 60–70% of KSMs are imported from China, making India vulnerable to supply chain disruptions. This dependency is particularly concerning for drugs like Digoxin, where any interruption in KSM supply can halt API production, leading to potential shortages.

Recent geopolitical tensions have exacerbated these risks. In June 2025, Iran's parliament voted to close the Strait of Hormuz, a critical chokepoint through which 20% of global oil transits. This action threatened to disrupt global supply chains, including the pharmaceutical sector, by increasing transportation costs and causing delays. (pharmasource.global) Such events highlight the fragility of India's API supply chain due to its reliance on Chinese KSMs and the potential for geopolitical events to disrupt essential material flows.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data from 2022 to 2026 indicates that the top five Indian exporters of Digoxin account for 60.3% of total exports, with SUN PHARMACEUTICAL INDUSTRIES LIMITED alone contributing 45.6%. This high supplier concentration poses a significant risk; any operational or regulatory issues affecting these key players could severely impact global Digoxin availability.

Access Complete Digoxin Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 886 transactions across 104 markets.

Request Demo View Pricing

Frequently Asked Questions — Digoxin Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top digoxin exporters from India?

The leading digoxin exporters from India are SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LTD, UNICURE REMEDIES PRIVATE LIMITED, and 10 others. SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with 45.6% market share ($993.4K). The top 5 suppliers together control 60.3% of total export value.

What is the total export value of digoxin from India?

The total export value of digoxin from India is $2.2M, recorded across 886 shipments from 203 active exporters to 104 countries. The average shipment value is $2.5K.

Which countries import digoxin from India?

India exports digoxin to 104 countries. The top importing countries are UNITED STATES (51.4%), SRI LANKA (5.7%), VENEZUELA (5.3%), CANADA (4.4%), NIGERIA (3.3%), which together account for 70.2% of total export value.

What is the HS code for digoxin exports from India?

The primary HS code for digoxin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Digoxin

Digoxin

Top Digoxin Exporters from India

Top Countries Importing Digoxin from India

Who Supplies Digoxin to India?

Quick Facts

Related Cardiovascular

Related Analysis

Need Details?

Regulatory Landscape — Digoxin

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Digoxin

Supply Chain Risk Assessment — Digoxin

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Digoxin Trade Intelligence

Frequently Asked Questions — Digoxin Exports from India

Who are the top digoxin exporters from India?

What is the total export value of digoxin from India?

Which countries import digoxin from India?

What is the HS code for digoxin exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of digoxin exports from India?

Which ports handle digoxin exports from India?

Why is India a leading exporter of digoxin?

What certifications do Indian digoxin exporters need?

How many buyers import digoxin from India?

What is the market share of the top digoxin exporter from India?

Analysis Methodology